Creating new capillary blood pools for practicing bidirectional medicine

• US 5,508,030 A
• Filed: 08/05/1993
• Issued: 04/16/1996
• Est. Priority Date: 08/05/1993
• Status: Expired due to Term

• Current Assignee: Howard R. Bierman
• Original Assignee: Howard R. Bierman
• Inventors: Bierman, Howard R.
• Primary Examiner(s): Sayala, Chhaya D.
• Application Number:
  US08/102,448
• Time in Patent Office: 985 Days
• Field of Search: 424/85.1, 424/85.2, 514/12, 514/23, 514/503, 514/573, 514/738, 514/355, 530/399, 562/503, 568/852, 546/316
• US Class Current: 424/85.1
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/22 of acyclic acids, e.g. pravastatin
• CPC Class Codes: A61K 31/44 Non condensed pyridines; Hydrogenated derivatives thereof
• CPC Class Codes: A61K 31/557 Eicosanoids, e.g. leukotrienes or prostaglandins
• CPC Class Codes: A61K 38/1825 Fibroblast growth factor [FGF]
• CPC Class Codes: A61K 38/1858 Platelet-derived growth factor [PDGF]
• CPC Class Codes: A61K 38/2026 IL-4
• CPC Class Codes: A61K 38/2285 Endothelin, vasoactive intestinal contractor [VIC]
• CPC Class Codes: A61K 9/7023 Transdermal patches and similar drug-containing composite devices, e.g. cataplasms galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006

Abstract

A process is disclosed for stimulating capillary growth to form a capillary pool in a predetermined location of a mammal'"'"'s body. This process creating a capillary pool may be used to introduce effective medications and other therapeutic agents unaltered in bio-availability through the skin which has been thinned to less than three millimeters thick. The capillary pool also permits detection of electrochemical signals from the circulating blood by sensors. These sensors can interpret chemical components of the blood such as oxygen, glucose, sodium, potassium and other elements and can be recorded from the sensor to devices that document chemicals in the blood continuously which is a much improved representation of what is happening physiologically without time restrictions. The capillary pool restores impaired blood circulation, facilitates removal of impurities from the blood, and can serve as a substitute blood supply for vascular-deficient body organs and tissues.

Claims

1. A method of creating a capillary blood pool in subcutaneous tissue below the skin of a mammal, comprising the steps of:

a) selecting an area of the skin of the mammal below which a capillary blood pool is to be developed within subcutaneous tissue of said mammal;

b) injecting a first solution of isotonic saline into the subcutaneous tissue below the selected area of skin of said mammal to form a well area of said solution in said tissue; and

c) injecting a second solution comprised of at least one angiogenic stimulant selected from the group of compounds consisting of 1-butyryl glycerol, alpha transforming growth factor, beta transforming growth factor, interleukin 1, interleukin 4, tumor necrosis factor, platelet derived growth factor, prostaglandin, hyaluronic acid fragments, nicotinamide and fibroblastic growth factor, into said well area thereby stimulating new capillary growth within said well area and forming a capillary blood pool therein.

2. The method of claim 1 wherein the skin of said mammal in the selected area of the skin is thinned to within 3 millimeters of the subcutaneous tissue below said selected area by the injection of saline.

3. The method of claim 1 wherein the location of the capillary blood pool is indicated by marking the skin of said mammal at the selected area.

4. The method of claim 1 wherein the time interval between the injection of said first solution and the injection of said second solution is between 2 and 24 hours.

6. The method of claim 1 wherein the selected area of the skin of said human subject below which said capillary blood pool is formed in a body location easily reached by said subject or other person administrating therapeutic medications via introduction into said blood pool.

7. The method of claim 1 wherein the first solution of isotonic saline in an amount of between about 3 cc and about 6 cc is injected less than 3 mm into subcutaneous tissue below the selected area of skin of said subject thus creating said well area and promoting the separation of fat tissues.

8. The method of claim 7 wherein the first solution of isotonic saline is injected into said subcutaneous tissue three or more times within a two hour period thereby creating a bubble of saline in said well area.

9. The method of claim 1 wherein the second solution, comprised of at least one angiogenic stimulant in a solution amount of between about 3 cc and about 10 cc, is injected into said well area from about 4 hours to about 24 hours after the creation of said well area by said first solution whereby said capillary blood pool is formed within about 7 days to about 21 days.

10. The method of claim 1 wherein the angiogenic stimulant or stimulants of said second solution stimulate endothelial cells within said well area to initiate formation of blood capillaries to form said blood pool.

11. The method of claim 1 wherein interleukin 4, endothelin and fiberblastic growth factor are angiogenic stimulants combined to form said second solution and promote rapid and effective formation of said capillary blood pool.

12. The method of claim 1 wherein B chain homodimer of platelet derived growth factor as an angiogenic stimulant having high mitogenic and neovascular activity forms said second solution.

5. A method of creating a capillary blood pool created in subcutaneous tissue below the skin of a human patient, comprising the steps of:

a) selecting an area of the skin of said patient readily accessible and visible to said patient and to a physician below which a capillary blood pool is to be developed within subcutaneous tissue of said patient;

b) injecting a first solution of isotonic saline into the subcutaneous tissue below the selected area of skin of said patient to form a well area of said solution in said tissue; and

c) injecting a second solution comprised of at least one angiogenic stimulant selected from the group of compounds consisting of 1-butyryl glycerol, alpha transforming growth factor, beta transforming growth factor, interleukin 1, interleukin 4, tumor necrosis factor, platelet derived growth factor, prostaglandin, hyaluronic acid fragments, nicotinamide and fibroblastic growth factor, into said well area thereby stimulating new capillary growth within said well area and forming a capillary blood pool therein.